2024 Scientific Sessions Agenda

 

Thursday, May 30, 2024
4:00 PM - 6:00 PM

NLA Opening Session - Exploring Divergent Perspectives on Lp(a) and LDL-C Management

4:00 PM - 4:30 PM Registration and Refreshments 
4:30 PM - 4:35 PM

Introduction and Pretest - James A. Underberg, MD, MS, FACP, FACPM, FASH, MNLA

4:35 PM - 4:55 PM

Clinical Counterpoints Case 1 - Payal Kohli, MD, FACC

4:55 PM - 5:00 PM Question and Answer
5:00 PM - 5:20 PM

Clinical Counterpoints Case 2 - Christie M. Ballantyne, MD

5:20 PM - 5:25 PM Question and Answer
5:25 PM - 5:45 PM

Clinical Counterpoints Case 3 - Alan S. Brown, MD, FACC, FAHA, FASPC, MNLA  

5:45 PM - 5:50 PM Question and Answer
5:50 PM - 6:00 PM

Posttest and Question & Answer

6:00 PM - 7:00 PM Welcome Reception
7:15 PM - 9:15 PM

Non-CME/CE Satellite Symposium

This is an independent satellite Non-CME/CE symposium held in conjunction with the NLA 2024 Scientific Sessions. It is not part of the official sessions as planned by the NLA Scientific Meetings Committee. Dinner to be provided by the NLA.

 

Friday, May 31, 2024
7:00 AM - 8:40 AM

CME/CE Satellite Symposium- Advances in Understanding Lipodystrophy Syndromes: From Rare to Relevant

This is an independent satellite CME/CE symposium held in conjunction with the NLA 2024 Scientific Sessions. It is not part of the official sessions as planned by the NLA Scientific Meetings Committee. Breakfast to be provided by the NLA.

8:00 AM - 9:00 AM Breakfast
9:00 AM - 9:10 AM Opening Remarks
9:10 AM - 10:15 AM Session I — Genetic Basis of Lipid/Lipoprotein Disorders and Cardiovascular Risk: An Expert Panel Discussion
 

Christie M. Ballantyne, MD, FNLA

Robert A. Hegele, MD, FRCPC, Cert Endo

Daniel J. Rader, MD, FNLA

Daniel E. Soffer, MD, FNLA

10:15 AM - 11:00 AM Session II — Publications from the NLA

10:15 AM - 10:20 AM

Pre-Session Assessment
10:20 AM - 10:30 AM Role of Apolipoprotein B in Clinical Management Daniel E. Soffer, MD, FNLA
10:30 AM - 10:40 AM

A Focused Update to the 2019 NLA Scientific Statement on the Use of Lipoprotein(a) in Clinical Practice

Christie M. Ballantyne, MD, FNLA
10:40 AM - 10:50 AM

Obesity, Dyslipidemia, and Cardiovascular Disease Risk:

A Joint Expert Review from the Obesity Medicine Association and the National Lipid Association 2024

Harold E. Bays, MD, FNLA
10:50 AM - 11:00 AM Post-Session Assessment and Question & Answer Panel
11:00 AM - 12:05 PM Lunch
11:00 AM - 11:50 AM Expert Theaters
12:05 PM - 1:30 PM Session III — Cardiorheumatology
12:05 PM - 12:10 PM Pre-Session Assessment
12:10 PM - 12:30 PM

Fundamentals of Inflammation and Cardiovascular Implications

Michael S. Garshick, MD, MS
12:30 PM - 12:50 PM

Basic and Clinical Science Connecting Psoriasis and Cardiovascular/Cardiometabolic Outcomes

Joel Gelfand, MD
12:50 PM - 1:10 PM Is Colchicine for ASCVD? Inflammatory Disease? Vijay Nambi, MD, PhD, FNLA
1:10 PM - 1:30 PM Post-Session Assessment and Question & Answer Panel
1:30 PM - 3:00 PM Abstract Author Q&A
3:00 PM - 4:25 PM

Session IV — Woman’s Cardiovascular Challenges

3:00 PM - 3:05 PM Pre-Session Assessment
3:05 PM - 3:25 PM Cardiovascular Concerns in Pregnancy Jennifer Lewey, MD, MPH
3:25 PM - 3:45 PM PCOS in Adolescents: A Pediatrician’s Challenge Silva Arslanian, MD
3:45 PM - 4:05 PM Menopause and the Heart: What a Clinician Needs to Know Chrisandra Shufelt, MD, MS, FACP, MSCP
4:05 PM - 4:15 PM Dyslipidemia Management in Women of Reproductive Potential: A Clinical Perspective from the National Lipid Association Anandita Agarwala Kulkarni, MD
4:15 PM - 4:35 PM Post-Session Assessment and Question & Answer Panel
6:00 PM - 8:00 PM

CME/CE Satellite Symposium

This is an independent satellite CME/CE symposium held in conjunction with the NLA 2024 Scientific Sessions. It is not part of the official sessions as planned by the NLA Scientific Meetings Committee. Dinner to be provided by the NLA.

 

Saturday, June 1, 2024
8:00 AM - 9:00 AM Expert Theater(s)
8:00 AM - 9:00 AM Breakfast
9:00 AM - 9:10 AM Opening Remarks
9:10 AM - 9:30 AM NLA Incoming President’s Address
  Christie M. Ballantyne, MD, FNLA
9:30 AM - 10:05 AM W. Virgil Brown Distinguished Achievement Lecture
  Robert A. Hegele, MD, FRCPC, Cert Endo
10:05 AM - 10:10 AM Abstract Author Q&A
10:10 AM - 11:00 AM Non-CME Special Session
11:05 AM - 11:55 AM Session V — Oral Poster Presentations
11:05 AM - 11:15 AM Oral Poster 3 - (141) Obicetrapib Alone and with Ezetimibe Reduces Non-HDL-C by Enhanced LDL-receptor-mediated VLDL Clearance and Increased Net Fecal Sterol Excretion José Inia, PhD
11:15 AM - 11:25 AM Oral Poster 2 - (186) The Long-Term Efficacy and Safety of Evinacumab in Pediatric Patients with Homozygous Familial Hypercholesterolemia Patrick Moriarty, MD
11:25 AM - 11:35 AM Oral Poster 1 - (117) A Randomized, Placebo-Controlled Phase 3 Study of Olezarsen In Patients With Familial Chylomicronemia Syndrome: The Balance Trial Robert Hegele, MD
11:35 AM - 11:45 AM Young Investigator Winner- (200) Pericardial and Pleural Effusions After Evolocumab In a Patient with Severe Familial Hypercholesterolemia Tia Bimal, MD
11:45 AM - 11:55 AM Hunninghake Award Winner TBD
11:55 AM- 12:10 PM NLA Business Meeting and Abstract Awards
12:10 PM - 12:50 PM Late Breakers
12:50 PM - 2:00 PM Lunch
12:50 PM - 1:40 PM Expert Theaters
2:00 PM - 3:25 PM Session VI — From a to B, then Back to LDL: Transatlantic Views on the Lipoproteins that Cause Plaque
Jointly Sponsored Session with National Lipid Association and European Atherosclerosis Society
2:00 PM - 2:05 PM Pre-Session Assessment
2:05 PM - 2:17 PM Disaggregating the Lipid Panel - Why Should I Bother? Christie M. Ballantyne, MD, FNLA
2:17 PM - 2:29 PM Lp(a) - Who to Measure and What to do About it? Florian Kronenberg, MD, MAE
2:29 PM - 2:41 PM To ApoB or Not ApoB Daniel E. Soffer, MD, FNLA
2:41 PM - 2:53 PM

LDL-C Lowering Across the Spectrum of Dyslipidemias - Why it Remains the Primary Target

Professor Kausik Ray, MD, FMedSci
2:53 PM - 3:03 PM Panel Discussion
3:03 PM - 3:25 PM Post-Session Assessment and Question & Answer Panel
3:25 PM - 3:35 PM Break
3:35 PM - 5:00 PM Session VII — Make It Happen…
3:35 PM - 3:40 PM Pre-Session Assessment
3:40 PM - 4:00 PM The Community BP Model - Can this be Expanded to Lipids? Norissa Haynes, MD, MPH, MSHP
4:00 PM - 4:20 PM Community Engaged Approaches to Obesity Prevention Senbagam Virudachalam, MD, MSHP
4:20 PM - 4:40 PM Implementing Lipid Management in the Health System - Where We Are and Where We Are Heading Nihar R. Desai, MD, MPH
4:40 PM - 5:00 PM Post-Session Assessment and Question & Answer
5:45 PM - 7:00 PM Honors and Awards Ceremony
7:00 PM - 8:00 PM

"Viva Las Vegas" Foundation Reception

 

Sunday, June 2, 2024
7:00 AM - 7:45 AM Zumba with NLA President-Elect Christie M. Ballantyne, MD, FNLA
8:00 AM - 9:00 AM Breakfast
9:00 AM - 9:10 AM Opening Remarks
9:10 AM - 10:55 AM Session VIII — Putting it Together in the Clinic for the Community and the Individual
9:10 AM - 9:15 AM Pre-Session Assessment
9:15 AM - 9:35 AM Treating the Health System Mary Katherine Cheeley, PharmD, FNLA
9:35 AM - 9:55 AM The Adolescent with Moderate-Severe Hypertriglyceridemia and Insulin Resistance Ann Liebeskind, MD, FNLA
9:55 AM - 10:15 AM Differing Treatment Approaches in Underserved Communities - The Contrast of West Philadelphia to Rural New Mexico Lauren A. Eberly, MD, MPH
10:15 AM - 10:35 AM Consultative Cases in Clinical Lipidology James A. Underberg, MD, MS, MNLA
10:35 AM - 10:55 AM Post-Session Assessment and Question & Answer Panel
10:55 AM Adjourn